- Hello, Jeff - If you read down the page, at
the very end, it is stated that "a bifurcated needle should not
be reprocessed and reused more than 50 times."
-
- Patricia Doyle
-
-
- 8. 2002 CDC Recommendations for Handling,
Cleaning, and Sterilizing Bifurcated
- Immunization Needles in Healthcare Settings
-
- Background
-
- Sterile, bifurcated needles are used to
administer smallpox immunization. The needles are designed to
hold the designated dose of vaccine (2.5l) between the needle
prongs to allow delivery to the skin surface. Once on the skin,
the needle is used to make 15-16 superficial punctures at the
vaccination site to permit percutaneous penetration of the
vaccine. Trace amounts of blood at the vaccination site are
evidence of successful vaccine delivery. Bifurcated needles may
arrive from the manufacturer sterilized and individually
wrapped, or in bulk, requiring subsequent sterilization prior to
use. These needles are intended for single-patient use followed
by disposal in a puncture-resistant sharps container. Because of
limited supplies, especially during mass vaccination programs,
it may be necessary to reprocess and reuse these needles.
-
- The strategies and procedures described here
are restricted to the cleaning and reprocessing of bifurcated
needles ONLY.
-
- Protocols for reprocessing bifurcated
needles must address: 1) the prevention of blood exposures and
patient-to-patient transmission of bloodborne viruses (i.e.,
hepatitis B and C viruses [HBV, HCV], and human immunodeficiency
virus [HIV]); and 2) prevention of sharps injury and
occupational transmission of bloodborne viruses to healthcare
personnel. The following procedures are designed to protect both
patients and healthcare personnel involved in smallpox
vaccination programs.
-
- 1. Initial Sterilization of Unsterile
Bifurcated Needles Received From the Manufacturer in Bulk
Supply. Needles received in bulk from the manufacturer should be
assumed to be clean and ready for packaging and sterilization.
If there is any concern regarding the cleanliness of these
items, they should be cleaned then sterilized as described
below.
-
- 2. Identify Resources. Identify equipment
and personnel to carry out reprocessing. The reprocessing area
should either have an ultrasonic bath, commercial dishwasher,
and an autoclave or dry heat sterilizer. The area should be of
sufficient size to have clearly demarcated dirty and clean
areas. The flow of traffic should always be from dirty to clean.
-
- 3. Methods for Reprocessing Bifurcated
Needle. Moist heat sterilization (i.e., autoclaving) or dry heat
sterilization are the preferred methods for sterilizing cleaned
bifurcated needles. However, boiling or flaming, as described
below, may be used if an autoclave or a forced air dry heat oven
is not available. These alternative methods have some historical
precedence, especially in developing nations, but have not been
validated. A. Care in handling. To prevent worker injury, used
needles should be handled as little as possible during
reprocessing. The use of fine mesh containers with secure tops
that facilitate containment and transfer during reprocessing is
preferred. Tongs, forceps, hemostats, or other devices that
eliminate the need for hands-on contact with needles should be
used to transfer them from their container.
-
- B-17B. Cleaning
-
- Used needles MUST BE CLEANED prior to
sterilization. Place needles in a soaking solution immediately
after use and prior to any physical cleaning. Soaking will
facilitate cleaning by preventing blood and organic soil from
drying on the needle. Commercial products used by healthcare
facilities for soaking contaminated instruments (e.g., any
detergent, detergent-disinfectant, enzyme formulation/cleaner)
are appropriate for this purpose. Do not use alcohol,
glutaraldehyde, or formaldehyde as a soaking solution for the
needles (these will fix protein to the needle surfaces). Also
avoid use of strong oxidizing solutions (hypochlorites,
peroxides, peracetic acid) because these may damage the needle
tip,. Transport used needles in the soaking solution (cover or
cap the container) and send to designated area for cleaning and
reprocessing. Automated cleaning with an ultrasonic cleaning
device or commercial dish/glassware washer is preferred to
manual cleaning as there is less opportunity for worker injury.
The manufacturer's instructions for use of the device should be
followed.
-
- The needles should then be rinsed with
potable water, and allowed to air dry on a clean surface .
Personnel should wear gloves during the cleaning process and use
transfer devices (e.g., tongs, forceps, or hemostats) as needed
to avoid direct handling of needles. C. Autoclaving. Bifurcated
needles that have been cleaned and dried are ready to be
packaged and autoclaved. Needles may be individually wrapped or
placed in groups of 10 to 15 in plastic/paper peel-down packages
or pouches, or clean screw-top glass container, and autoclaved.
The bifurcated end of the needle should point toward the bottom
of the tube/ pouch away from the opening to allow easy aseptic
retrieval. The manufacturer's instructions for use of the
autoclave should be followed. Sterilization times will vary
depending on temperature and load (i.e., 121ºC for 30 minutes or
133ºC for 4 minutes).
-
- The tubes/packs should be placed in a rack
or carrier that holds the tubes in a horizontal or slightly
slanted position to ensure that the steam will penetrate fully
to the bottom. During autoclaving, tops of glass tubes should be
loose enough to allow penetration of steam and prevent breakage
of the container. After autoclaving and cooling, caps should be
tightly screwed. D. Dry Heat Sterilization. Screw capped glass
test tubes are the best choice for dry heat sterilization. Clean
and package bifurcated needles as above for glass tubes (i.e.,
cap tubes but leave loose enough to allow for air). The needles
can be placed in a dry heat oven and baked as follows: (i) 170°C
for 60 minutes; (ii) 160°C for 120 minutes; (iii) 150°C for 150
minutes; (iv) 140°C for 180 minutes; or (v) 121°C overnight.
-
- B-184. Other Sterilization Alternatives
-
- Boiling and flaming are alternative methods
for sterilizing bifurcated needles, but should be used only when
other options are not available.
-
- A. Boiling. After cleaning, needles that
will be reused may be placed in boiling water for 20 minutes,
allowed to air dry, and then stored in a sterile receptacle. To
minimize handling before and after sterilization heat-resistant
fine mesh containers should be used where possible. If such
containers are not available, a transfer device (e.g., tongs,
forceps, hemostat) should be used to insert and remove needles
from the water bath. The transfer device should be boiled along
with the needles to facilitate aseptic removal. Although the
handle of the transfer device need not be immersed in the
boiling water, it will become very hot during needle
reprocessing. Care should be taken to prevent burn injury during
handling. Needles must be thoroughly dried to ensure that no
residual water enters the vaccine vial. This is best
accomplished by placing the needles on one half of an absorbent,
plastic-backed, sterile barrier and folding the other have over
the needles, providing a protective cover. When dry, the needles
should be transferred aseptically into a dry sterile container
(e.g., glass tube) with the bifurcated ends pointed away from
the opening to permit aseptic retrieval. The top of the
receptacle should be secured tightly to prevent contamination.
-
- B. Flaming. In the past, flaming has been
used to reprocess bifurcated needles, but no data exists on
sterilization efficacy. Flaming should be used only when the
needle must be reused immediately (i.e., a mass vaccination
campaign is underway, vaccine recipients are present, and a
supply of new or reprocessed sterile needles is not available)
and only when none of the other sterilization methods described
above are available. Pass the bifurcated end of the needle
through the flame of an alcohol lamp or Bunsen burner. If an
alcohol burner is used, the concentration of the alcohol must be
95% for adequate burn. The optimal duration of exposure to the
flame is not known. The needle must become sufficiently hot to
allow sterilization. However, to maintain needle integrity, the
needle should not remain in the flame for more than 3 seconds.
Measures should be taken to prevent burn injury to the fingers
by handling the blunt end of the needle with a non-conductive
device (i.e., forceps or tweezers with rubber or hard plastic
handles). Allow the needle to cool completely before inserting
into the vaccine. Flaming is not considered a terminal
reprocessing procedure as it does not provide an environment for
maintaining sterile conditions. If needles that have been flamed
for immediate reuse will be used again in the future, they
should be cleaned and sterilized (autoclaving, baking, or
boiling), as described above.
-
- Frequency Of Reuse
-
- A bifurcated needle should not be
reprocessed and reused more than 50 times. Reports have shown
that vaccination effectiveness was reduced to 80.8% with needles
used 86 to 172 times.
-
- Procedures should be established to monitor
the frequency of needle reuse. Prevention of cross-contamination.Patient-to-patient
transmission of bloodborne viruses has been associated with
contamination of multi-dose vials. To prevent opportunity for
such transmission, a contaminated needle should never be allowed
to reenter a vaccine vial. Furthermore, surfaces where vaccine
is being handled should be free of visible blood, body fluids or
other organic soil. Preparation of vaccine and needle
reprocessing should be physically separate. If a contaminated
needle is inadvertently redipped into a vaccine vial, that vial
should be removed and not used for further vaccination.
-
-
-
- Patricia A. Doyle, PhD
- Please visit my "Emerging Diseases" message
board at:
- http://www.clickitnews.com/emergingdiseases/index.shtml
- Zhan le Devlesa tai sastimasa
- Go with God and in Good Health
At Rense.com, YOUR comments are always
welcome!
MainPage
http://www.rense.com
Note from
HCVets.com:
The
smallpox vaccine is made from a live virus related to smallpox called vaccinia,
not the smallpox virus. It was made by infecting calves with vaccinia and
scraping off pustules that formed on their sides. That method would never be
approved by the Food and Drug Administration today.
The Immunity to vaccinia also provides immunity to smallpox. The vaccine stimulates the immune system to react against the vaccinia
virus, and develop immunity to it. In 1982, the only active licensed producer of
vaccinia vaccine in the United States, were the makers of military vaccines,
Wyeth Laboratories. In 1983, distribution to the civilian population was
discontinued.
General
Studies in the 1950’s and 1960’s indicated that complications of Small pox
vaccination appeared to occur soon after vaccination and before significant
antibodies could be detected in the blood. As a result, Vaccinia Immune Globulin
(VIG) was used to help people who have certain serious reactions. VIG is a human
immune globulin made from blood plasma of people who received
the smallpox vaccine more than once (usually many times). The part of the blood
(antibodies) that gives protection from vaccinia infection is taken out
(fractionated), and called hyper immune globulin, providing instant antibodies to
patients to fight complications from calf vaccinia.
Studies
from the 60's and 70's revealed the most serious complications of Calf Vaccinia,
was post-vaccine encephalitis (liver failure). In one study focused on 1968 , patients with suspected
complications received VIG from the American Red Cross
and represented the majority (82.5%) of the cases of encephalitis
(liver failure), necrosum, and eczema.
The
fractionation processes, at all four plants processing VIG, Wyeth, Cutter,
Baxter and Connaught, in Canada, purchased hyper immune blood from
prisons declared in "Hepatitis epidemic status" since 1965.
These companies, including the red cross, were continuously sited by the
FDA for violations of Good Manufacturing procedures for sanitary processes and
equipment. Prior to 1982 manufactures did not screen donors. Blood
products were not heated or filtered and equipment used to fractionate and
lyophilized (freeze dry for jet gun injections) products were not sterilized.
The
vaccine formulations for small pox and VIG now available are not formulated for
the jet injector gun. VIG was administered with the jet guns during Vietnam
service and studies trace the use of Small pox virus, VIG and jet guns
to Brazil in the 70's, with one of the highest HCV rates in the world.
Before
the jet guns were used in the late 60's, the smallpox vaccine was given using a
bifurcated (two-pronged) needle that is dipped into the vaccine solution.
When removed, the needle retains a droplet of the vaccine. The needle is then
used to quickly prick the skin 15 times in a few seconds. The pricking is not deep,
but it will cause a sore spot but does cause one or two drops of blood to form.
They reused these bifurcated needles and only soaked in them in Alcohol. The
vials of smallpox vaccine were used over and over. Reuse of vials for any
injections prove to be a very high risk avenue for HCV transmission.
Vaccination and the occurrence of complications ceased in the early 1970’s when
the process to fractionate the plasma changed. The first purified human
immunoglobulin G (IgG) preparation used clinically was immune serum globulin
(ISG), which was prepared in the 1940s by E. J. Cohn's group. The next
generation of purified IgG (Gamimune, Cutter
Biological), began in
the 1960s and the formulation altered again in 1972. A third generation of
purified IgG was developed in 1986 and the last generation formulated in 1992.
Today,
the safety of HCV-RNA-positive Intramuscular immunoglobulin preparations can be
attributed to several factors: (1) partitioning of viruses away from
immunoglobulin, (2) inactivation of viruses by the fractionation
process, and (3) a high concentration of neutralizing antibodies
Other manufacturing procedures do not ensure the same safety.
New
UPDATE:
Safety and availability of immunoglobulin replacement therapy in relation to
potentially transmissable agents Clinical
& Experimental Immunology Volume 118 Issue s1 Page 29
- October 1999... However, the role of partitioning of viruses cannot be taken
in isolation; when antibodies to HCV were removed following the introduction of
screening, the amount of recoverable HCV-RNA in the various Cohn fractions
changed dramatically as a result of the virus no longer being complexed with
antibody. 28 ...As Cohn–Oncley
fractionation is not sufficient to remove lipid-coated viruses, additional
antiviral inactivation steps are required.
Read more
Subcutaneous injections of a drug
containing human immunoglobulins
Infect Dis 1977 Feb;135(2):252-8 Petrilli FL, Crovari P, De Flora Since late
1974 and early 1975, several cases of viral hepatitis were reported in Italy
among subjects who had received subcutaneous injections of a drug containing
human immunoglobulins that was prescribed for the treatment of allergies.
Epidemiologic and laboratory investigations provided evidence that the original
immunoglobulins, the series of the drug containing these immunoglobulins, and
sera from a number of patients were all positive for hepatitis B surface antigen
(HBs Ag) of the adw subtype, which is relatively rare in Italy.
Transfusion 1992
Nov-Dec;32(9):824-8 Recovery of
hepatitis B antibody from human plasma products separated by a modified Cohn
fractionation.
Vox Sang 1974;27(4):302-9Berg JV, Berntsen KO, Bjorling H, Holmstrom B, Vyas GN
PMID: 4213354, UI: 75014376
Referances
SMALLPOX SUPPLEMENTAL FACT
SHEET INVESTIGATIONAL VACCINIA IMMUNE GLOBULIN (VIG)
INFORMATION
http://oph.dhh.state.la.us/infectiousdisease/bioterror/smallpox/docs/VIG_1_16.pdf
Lane JM, Ruben FL, Neff JM, Millar JD.
Complications of smallpox vaccinations, 1968: national surveillance in the
United States. New Engl J Med 1969;281:1201-1208.
http://www.doh.state.fl.us/Disease_ctrl/immune/smallpox/clinician_packet/1%20Core%20Infornation/9_ad
ON THE TRAIL OF TAINTED
BLOOD -- HEMOPHILIACS SAY U.S. COULD HAVE PREVENTED THEIR CONTRACTING AIDS Donna
Shaw, INQUIRER STAFF WRITER Philadelphia Inquirer; FINAL Section: EDITORIAL
REVIEW & OPINION Page: E01 SUNDAY April 16, 1995
http://hcvets.com/data/transmission_methods/published_articles/philadelphia_inquirer.htm
PRISON DRUG & PLASMA
PROJECTS LEAVE FATAL TRAIL The New York Times, Page 1 July 29, 1969
By WALTER RUGABER Washington, July 28 -- http://hcvets.com/data/transmission_methods/published_articles/new_york_times_1969.htm
Three generations of
immunoglobulin G preparations for clinical use.
McCue JP, Hein RH, Tenold R Rev Infect Dis 1986 Jul-Aug;8 Suppl 4:S374-81
Immunoglobulin Transmits Hepatitis C. True or
False?
Hepatology, January 1999, p. 299-300, Vol. 29, No. 1
http://hcvets.com/data/transmission_methods/published_articles/immunoglobulin_transmits_hepatit.htm
THE SMALLPOX VACCINE
David Snodgrass of Tucson, AZ asks:
__________________________________
Is the use of a jet injector gun the best
way to administer the vaccination? In 1967, if memory serves,
that was the method used to give me the vaccine.
Medical epidemiologist Dr. Lisa Rotz responds:
___________________________
The vaccine formulations now available are not formulated for
the jet injector gun. Current day problems [with jet injector
guns] include concerns about transmission of other infectious
diseases such as hepatitis (there have been some outbreaks). The
smallpox vaccine is not given with a hypodermic needle. It is
not a "shot," like many vaccinations. The vaccine is given using
a bifurcated (two-pronged) needle that is dipped into the
vaccine solution. When removed, the needle retains a droplet of
the vaccine. The needle is then used to quickly prick the skin
15 times in a few seconds. The pricking is not deep, but it will
cause a sore spot and one or two drops of blood to form. The
vaccine usually is given in the upper arm.
If the vaccination is successful, a red and itchy bump develops
at the vaccination site in three or four days. In the first week
after vaccination, the bump becomes a large blister, fills with
pus, and begins to drain. During week two, the blister begins to
dry up and a scab forms. The scab falls off in the third week,
leaving a small scar. People who are being vaccinated for the
first time may have a stronger "take" (a successful reaction)
than those who are being revaccinated.
http://www.pbs.org/newshour/health/bioterrorism/forum.html.
Home
Methods
The
Liver VA
New
|